Archives
-
Clathrin-Mediated Entry of Grass Carp Reovirus: Mechanisms a
2026-05-25
Wang et al. (2018) systematically defined clathrin-mediated, pH-dependent endocytosis as the main route for type III grass carp reovirus (GCRV104) entry into kidney cells. Their inhibitor-based approach clarifies cellular mechanisms of infection and provides a foundation for targeted antiviral strategies in aquaculture research.
-
3-Bromopyruvate and Cetuximab: Overcoming CRC Resistance via
2026-05-24
This article reviews recent research demonstrating that co-treatment with 3-bromopyruvate (3-BP) and cetuximab can overcome drug resistance in mutant colorectal cancer cells by inducing autophagy-dependent ferroptosis and apoptosis. The study elucidates mechanistic pathways involving FOXO3a modulation and highlights new strategies for addressing refractory colorectal cancer.
-
Magnetic Stimulation Downregulates Gabre to Alleviate SCZ Be
2026-05-23
This study demonstrates that targeted magnetic stimulation of the mouse left prelimbic cortex downregulates the GABAA receptor ε subunit, reversing schizophrenia-like behaviors and synaptic deficits. The findings reveal a mechanistic link between noninvasive brain stimulation and GABAergic modulation, highlighting Gabre as a promising target for future schizophrenia interventions.
-
Sulfo-Cy5 Carboxylic Acid: Benchmark Fluorescent Dye for Lif
2026-05-22
Sulfo-Cy5 carboxylic acid is a sulfonated hydrophilic fluorescent dye with high water solubility and minimized fluorescence quenching, making it a preferred choice for protein and peptide labeling in aqueous environments. Its robust photophysical properties and compatibility with advanced immunological workflows establish it as a benchmark tool for fluorescence imaging in life sciences.
-
PPM-18: A Precision Tool for iNOS/NF-κB Pathway Dissection i
2026-05-22
Explore how PPM-18 (N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide) enables high-resolution analysis of iNOS and NF-κB signaling in sepsis and inflammation research. This article uniquely bridges mechanistic insight with practical assay design for advanced immune modulation studies.
-
RG7388: Selective Oral MDM2 Antagonist for p53 Pathway Activ
2026-05-21
RG7388 is a highly selective, orally bioavailable MDM2 antagonist that disrupts the p53-MDM2 interaction and induces apoptosis in wild-type p53 cancer cells. Its superior potency and synergy with chemoradiotherapy offer promise for precision oncology applications.
-
BMX Kinase-Driven ATP6V1E1 Phosphorylation Enables Mtb Survi
2026-05-21
This study reveals that Mycobacterium tuberculosis (Mtb) manipulates host BMX kinase to phosphorylate ATP6V1E1, inhibiting lysosomal acidification and promoting intracellular survival. The findings highlight a novel host-pathogen interaction and suggest that targeting BMX kinase could be a promising strategy for host-directed tuberculosis therapy.
-
Pifithrin-α: Applied Protocols and Innovations for p53 Inhib
2026-05-20
Pifithrin-α (PFTα) stands out as a selective p53 inhibitor, enabling precise modulation of apoptosis, ferroptosis, and cell cycle responses in complex models. By integrating recent breakthroughs in neurotoxicity and ferroptosis, this guide delivers actionable protocols, troubleshooting strategies, and cross-study insights for advanced research.
-
Viperin Disrupts Coronavirus RTC via nsp8 Targeting and ddhC
2026-05-20
The reference study reveals a dual antiviral mechanism by which viperin inhibits coronavirus replication: direct protein-protein disruption of the replication-transcription complex (RTC) through binding viral nsp8, and enzymatic production of ddhCTP, which prematurely terminates viral RNA synthesis in susceptible coronaviruses. These findings expand the understanding of interferon-stimulated antiviral defense and identify new molecular targets for broad-spectrum antiviral strategies.
-
Nirmatrelvir (PF-07321332): Applied Workflows in Antiviral R
2026-05-19
Nirmatrelvir (PF-07321332) enables precise SARS-CoV-2 replication inhibition by targeting the 3CL main protease, streamlining both mechanistic and translational studies. This guide details experimental setup, troubleshooting, and workflow enhancements to maximize impact in COVID-19 antiviral therapeutics research.
-
AM 281: Applied Workflows for CB1 Cannabinoid Receptor Antag
2026-05-19
AM 281, a potent and selective CB1 cannabinoid receptor antagonist, is rapidly redefining neuropharmacology protocols. This guide delivers data-driven, actionable insights for memory impairment research and traumatic brain injury models, while addressing advanced troubleshooting and implementation strategies.
-
Thapsigargin: Quantitative Approaches to ER Stress and Apopt
2026-05-18
Explore how Thapsigargin, a potent SERCA pump inhibitor, enables quantitative, reproducible interrogation of endoplasmic reticulum stress and apoptosis in cell models. This article delivers advanced protocol guidance and a critical synthesis of recent translational research, distinguishing itself by focusing on assay optimization and decision-making.
-
Pseudo-UTP: Elevating mRNA Synthesis with Pseudo-modified Ur
2026-05-18
Pseudo-UTP sets a new benchmark for mRNA synthesis, empowering researchers to achieve superior RNA stability, translation efficiency, and reduced immunogenicity. Its integration into in vitro transcription workflows catalyzes advances in vaccine design, gene therapy, and next-generation RNA-based therapeutics.
-
Fluorouracil (Adrucil): Molecular Precision in Targeting DNA
2026-05-17
Discover how Fluorouracil (Adrucil) uniquely disrupts DNA replication in colon and breast cancer research. Explore advanced mechanistic insights, protocol optimization, and translational relevance supported by recent breakthroughs.
-
EdU Imaging Kits (Cy5): Advancing S-Phase Assays in Genotoxi
2026-05-16
Discover how EdU Imaging Kits (Cy5) deliver unparalleled sensitivity for DNA synthesis measurement in cell proliferation and genotoxicity studies. This article uniquely explores their mechanistic advantages, protocol optimization, and application insights informed by cutting-edge hepatoblastoma research.